| Control group | MDR group | p-value | MDR-AB | ESBL-E coli | ESBL-KP | MDR-Pseudomonus | MRSA | p-value |
---|---|---|---|---|---|---|---|---|---|
 | n=1108 | n=554 |  | n=214 | n=47 | n=99 | n=82 | n=102 |  |
Length of ward (days) | 12.6 ± 10.5 | 26.4 ± 22.3 | <0.001 | 27.3 ± 16.8 | 29.9 ± 20.5 | 27.3 ± 17.5 | 28.6 ± 42.2 | 20.3 ± 12.8 | 0.043 |
Length of ICU (days) | 9.8 ± 9.2 | 18.9 ± 14.2 | <0.001 | 19.3 ± 12.5 | 17.2 ± 16.9 | 20.0 ± 14.6 | 22.4 ± 18.5 | 13.7 ± 12.6 | 0.068 |
Respiratory failure | 137 (12.4%) | 229 (41.3%) | <0.001 | 97 (45.3%) | 11 (23.4%) | 41 (41.4%) | 36 (43.9%) | 41 (40.2%) | 0.096 |
 Invasive MV | 77 (6.9%) | 150 (27.1%) | <0.001 | 69 (32.2%) | 7 (14.9%) | 28 (28.3%) | 26 (31.7%) | 19 (18.6%) | 0.027 |
 Non-invasive MV | 89 (8.0%) | 125 (22.6%) | <0.001 | 42 (19.6%) | 7 (14.9%) | 22 (22.2%) | 21 (25.6%) | 31 (30.4%) | 0.156 |
Duration of ventilator (days) | 7.8 ± 7.4 | 17.9 ± 13.7 | <0.001 | 18.2 ± 12.8 | 17.1 ± 13.6 | 18.5 ± 13.9 | 21.6 ± 18.2 | 11.7 ± 9.1 | 0.033 |
Shock | 67 (6.1%) | 169 (30.5%) | <0.001 | 68 (31.8%) | 9 (19.2%) | 40 (40.4%) | 23 (28.1%) | 25 (24.5%) | 0.048 |
Inhospital mortality | 83 (7.6%) | 148 (26.7%) | <0.001 | 67 (31.3%) | 10 (21.3%) | 27 (27.3%) | 15 (18.3%) | 27 (26.5%) | 0.201 |
Convert to non-MDR | (%) | 233 (42.1%) | Â | 88 (41.1%) | 24 (51.1%) | 39 (39.4%) | 31 (37.8%) | 45 (44.1%) | 0.609 |
Time to non-MDR (days) | (%) | 27.2 ± 64.8 |  | 15.1 ± 29.1 | 37.5 ± 52.6 | 28.9 ± 87.1 | 32.8 ± 71.9 | 47.3 ± 94.8 | 0.004 |
3 year Respiratory failure | 150 (13.5%) | 186 (33.6%) | <0.001 | 79 (36.9%) | 11 (23.4%) | 35 (35.4%) | 35 (42.7%) | 23 (22.6%) | <0.001 |
 Invasive MV | 101 (9.1%) | 149 (26.9%) | <0.001 | 66 (30.8%) | 7 (14.9%) | 29 (29.3%) | 32 (39.0%) | 14 (13.7%) | <0.001 |
 Non-invasive MV | 87 (7.9%) | 84 (15.2%) | <0.001 | 30 (14.0%) | 6 (12.8%) | 14 (14.1%) | 13 (15.9%) | 18 (17.7%) | 0.001 |
3 year mortality | 460 (41.5%) | 406 (73.3%) | <0.001 | 166 (77.6%) | 32 (68.1%) | 80 (80.8%) | 48 (58.5%) | 71 (69.6%) | <0.001 |